多发性内分泌肿瘤 2B 型的临床试验
总计58577个结果
-
Shenzhen University General Hospital招聘中
-
Zhejiang UniversityYake Biotechnology Ltd.尚未招聘
-
Amgen完全的难治性多发性骨髓瘤 | 复发性多发性骨髓瘤加拿大, 比利时, 西班牙, 美国, 大韩民国, 澳大利亚, 捷克语, 台湾, 匈牙利, 奥地利, 罗马尼亚, 日本, 英国, 希腊, 火鸡, 保加利亚, 法国, 俄罗斯联邦, 波兰
-
Mario Boccadoro主动,不招人
-
Regeneron Pharmaceuticals主动,不招人
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; H. Lee Moffitt Cancer Center...完全的
-
Rabin Medical CenterHarvard University; DreaMed终止
-
University of SouthamptonNIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust; European... 和其他合作者终止
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
NCIC Clinical Trials Group完全的
-
University of Maryland, BaltimoreNational Cancer Institute (NCI); University of Maryland Greenebaum Cancer Center完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Roswell Park Cancer Institute完全的
-
Leeds Cancer Centre at St. James's University Hospital未知
-
California Cancer ConsortiumNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Institut Paoli-Calmettes完全的
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Zhejiang UniversityYake Biotechnology Ltd.招聘中
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLC招聘中多发性骨髓瘤 | 难治性多发性骨髓瘤 | 复发性多发性骨髓瘤美国
-
Takeda完全的
-
Ohio State University Comprehensive Cancer Center完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)主动,不招人